XML 75 R9.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Fair Value Measurements
9 Months Ended
Dec. 31, 2019
Fair Value Disclosures [Abstract]  
Fair Value Measurements
(2) FAIR VALUE MEASUREMENTS
There are various valuation techniques used to estimate fair value, the primary one being the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining fair value, we consider the principal or most advantageous market in which we would transact and consider assumptions that market participants would use when pricing the asset or liability. We measure certain financial and nonfinancial assets and liabilities at fair value on a recurring and nonrecurring basis.
Fair Value Hierarchy
The three levels of inputs that may be used to measure fair value are as follows:
Level 1. Quoted prices in active markets for identical assets or liabilities.
Level 2. Observable inputs other than quoted prices included within Level 1, such as quoted prices for similar assets or liabilities, quoted prices in markets with insufficient volume or infrequent transactions (less active markets), or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated with observable market data for substantially the full term of the assets or liabilities.
Level 3. Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of assets or liabilities.
Assets and Liabilities Measured at Fair Value on a Recurring Basis
As of December 31, 2019 and March 31, 2019, our assets and liabilities that were measured and recorded at fair value on a recurring basis were as follows (in millions):
 
 
 
Fair Value Measurements at Reporting Date Using
 
  
 
 
 
Quoted Prices in
Active Markets 
for Identical
Financial
Instruments
 
Significant
Other
Observable
Inputs
 
Significant
Unobservable
Inputs
 
 
 
As of
December 31, 2019
 
(Level 1)
 
(Level 2)
 
(Level 3)
 
Balance Sheet 
Classification
Assets
 
 
 
 
 
 
 
 
 
Bank and time deposits
$
85

 
$
85

 
$

 
$

 
Cash equivalents
Money market funds
1,352

 
1,352

 

 

 
Cash equivalents
Available-for-sale securities:
 
 
 
 
 
 
 
 
 
Corporate bonds
837

 

 
837

 

 
Short-term investments and cash equivalents
U.S. Treasury securities
459

 
459

 

 

 
Short-term investments and cash equivalents
U.S. agency securities
8

 

 
8

 

 
Short-term investments
Commercial paper
438

 

 
438

 

 
Short-term investments and cash equivalents
Foreign government securities
48

 

 
48

 


 
Short-term investments
Asset-backed securities
281

 

 
281

 

 
Short-term investments
Certificates of deposit
43

 

 
43

 

 
Short-term investments
Foreign currency derivatives
22

 

 
22

 

 
Other current assets and other assets
Deferred compensation plan assets (a)
14

 
14

 

 

 
Other assets
Total assets at fair value
$
3,587

 
$
1,910

 
$
1,677

 
$

 
 
Liabilities
 
 
 
 
 
 
 
 
 
Contingent consideration (b)
$
35

 
$
35

 
$

 
$

 
Accrued and other current
liabilities
Foreign currency derivatives
9

 

 
9

 

 
Accrued and other current liabilities and other liabilities
Deferred compensation plan liabilities (a)
14

 
14

 

 

 
Other liabilities
Total liabilities at fair value
$
58

 
$
49

 
$
9

 
$

 
 


 
 
 
 
Fair Value Measurements at Reporting Date Using
 
  
 
 
 
Quoted Prices in
Active Markets 
for Identical
Financial
Instruments
 
Significant
Other
Observable
Inputs
 
Significant
Unobservable
Inputs
 
 
 
As of March 31, 2019
 
(Level 1)
 
(Level 2)
 
(Level 3)
 
Balance Sheet Classification
Assets
 
 
 
 
 
 
 
 
 
Bank and time deposits
$
23

 
$
23

 
$

 
$

 
Cash equivalents
Money market funds
2,704

 
2,704

 

 

 
Cash equivalents
Available-for-sale securities:
 
 
 
 
 
 
 
 
 
Corporate bonds
327

 

 
327

 

 
Short-term investments and cash equivalents
U.S. Treasury securities
294

 
294

 

 

 
Short-term investments and cash equivalents
U.S. agency securities
57

 

 
57

 

 
Short-term investments and cash equivalents
Commercial paper
233

 

 
233

 

 
Short-term investments and cash equivalents
Foreign government securities
58

 

 
58

 

 
Short-term investments and cash equivalents
Asset-backed securities
55

 

 
55

 

 
Short-term investments and cash equivalents
Certificates of deposit
2

 

 
2

 

 
Short-term investments and cash equivalents
Foreign currency derivatives
33

 

 
33

 

 
Other current assets and other assets
Deferred compensation plan assets (a)
11

 
11

 

 

 
Other assets
Total assets at fair value
$
3,797

 
$
3,032

 
$
765

 
$

 
 
Liabilities
 
 
 
 
 
 
 
 
 
Contingent consideration (b)
$
136

 
$

 
$

 
$
136

 
Accrued and other current liabilities
Foreign currency derivatives
16

 

 
16

 

 
Accrued and other current liabilities and other liabilities
Deferred compensation plan liabilities (a)
12

 
12

 

 

 
Other liabilities
Total liabilities at fair value
$
164

 
$
12

 
$
16

 
$
136

 
 


(a)
The Deferred Compensation Plan assets consist of various mutual funds. See Note 15 in our Annual Report on Form 10-K for the fiscal year ended March 31, 2019, for additional information regarding our Deferred Compensation Plan.

(b)
The contingent consideration represents the estimated fair value of the additional variable cash consideration payable in connection with our acquisition of Respawn Entertainment, LLC (“Respawn”) that is contingent upon the achievement of certain performance milestones. As of March 31, 2019, we estimated fair value using a probability-weighted income approach combined with a real options methodology, and applied a discount rate that appropriately captures the risk associated with the obligation, ranging from 2.9 percent to 3.1 percent. During the nine months ended December 31, 2019, there were no material changes to the estimated fair value of the contingent consideration liability other than $105 million in payments for performance milestones achieved. As of December 31, 2019, all remaining performance milestones have been achieved and the $35 million remaining payment amount was fixed and was paid in the fourth quarter of fiscal year 2020. See Note 7 in our Annual Report on Form 10-K for the fiscal year ended March 31, 2019, for additional information regarding the Respawn acquisition.